Inogen schedules November 5 results: two analysts cover Inogen stock

Published on 10/20/2026 at 20:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached USD 95.10 million, up 3.00 percent year over year. Inogen stock was EUR 5.95 on October 20, 2026 at 8:11 p.m. CEST.

Reporting date and operating figures

Inogen scheduled third-quarter 2026 results for November 5, 2026.
Second-quarter 2026 revenue reached USD 95.10 million, up 3.00 percent year over year.
Inogen stock was EUR 5.95 at Lang & Schwarz on October 20, 2026 at 8:11 p.m. CEST.
Inogen had a USD 178.1 million market capitalization as of October 20, 2026.

INGN, US45780L1044, Illustration mit AI erstellt.

Inogen has scheduled its third-quarter 2026 financial results for November 5, 2026, according to the company investor-relations page dated October 15, 2026. Rallies listed two analysts covering Inogen on October 12, 2026. Inogen was trading at EUR 5.95 at Lang & Schwarz on October 20, 2026 at 8:11 p.m. CEST.

Results date sets the next checkpoint

The November 5 release will update investors on the period ending September 30, 2026. The date is listed on Inogen's investor-relations page, which also identifies the company as Nasdaq-listed and focused on respiratory medical technology.

Inogen's second-quarter 2026 revenue was USD 95.10 million, an increase of 3.00 percent from the prior-year period. Benzinga reported that international sales rose 15.00 percent year over year to USD 41.30 million, while U.S. sales fell 2.00 percent to USD 42.30 million.

Revenue growth meets channel pressure

The second-quarter 2026 figures show a split operating picture. International revenue expanded by USD 5.39 million from the prior-year period, while the U.S. business faced channel-mix pressure. Adjusted EBITDA reached USD 2.40 million, up 15.00 percent year over year, and gross margin increased to 45.50 percent from 44.80 percent.

Cash, cash equivalents, marketable securities and restricted cash totaled USD 106.80 million on June 30, 2026, with no debt outstanding. The company also reported USD 2.90 million of operating cash flow for the second quarter of 2026.

Valuation and November reporting date

Inogen had a USD 178.1 million market capitalization as of October 20, 2026. The next scheduled company event is the third-quarter 2026 financial-results release on November 5, 2026, at 5:00 p.m. ET.

Stock remains the market frame

The euro quotation provides the German investor view, while the company's operating figures remain reported in USD. The next results release will put international growth, U.S. channel trends and adjusted EBITDA against the second-quarter benchmarks.

The further course of trading is shown by the continuously updated real-time quote of Inogen stock.